TY - JOUR
T1 - Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma
AU - Trucco, Lucas D
AU - Mundra, Piyushkumar A
AU - Hogan, Kate
AU - Garcia-Martinez, Pablo
AU - Viros, Amaya
AU - Mandal, Amit K
AU - Macagno, Nicolas
AU - Gaudy-Marqueste, Caroline
AU - Allan, Donald
AU - Baenke, Franziska
AU - Cook, Martin
AU - McManus, Clare
AU - Sanchez-Laorden, Berta
AU - Dhomen, Nathalie
AU - Marais, Richard
N1 - Funding Information:
This work was supported by CRUK-MI (A27412 and A22902) and the European Research Council (ERC Advanced Grant agreement No. 671262) to R.M. C.G-M. was supported by the French Society of Dermatology, UNICANCER and CEDEF. We acknowledge the contribution of the CRUK-MI core facilities and the contribution of the melanoma specimen donors.
Publisher Copyright:
© 2018, The Author(s), under exclusive licence to Springer Nature America, Inc.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2018/12/3
Y1 - 2018/12/3
N2 - The melanoma genome is dominated by ultraviolet radiation (UVR)-induced mutations. Their relevance in disease progression is unknown. Here we classify melanomas by mutation signatures and identify ten recurrently mutated UVR signature genes that predict patient survival. We validate these findings in primary human melanomas; in mice we show that this signature is imprinted by short-wavelength UVR and that four exposures to UVR are sufficient to accelerate melanomagenesis.
AB - The melanoma genome is dominated by ultraviolet radiation (UVR)-induced mutations. Their relevance in disease progression is unknown. Here we classify melanomas by mutation signatures and identify ten recurrently mutated UVR signature genes that predict patient survival. We validate these findings in primary human melanomas; in mice we show that this signature is imprinted by short-wavelength UVR and that four exposures to UVR are sufficient to accelerate melanomagenesis.
UR - http://www.scopus.com/inward/record.url?scp=85058061858&partnerID=8YFLogxK
UR - https://rdcu.be/ctM19
U2 - 10.1038/s41591-018-0265-6
DO - 10.1038/s41591-018-0265-6
M3 - Article
C2 - 30510256
SN - 1078-8956
VL - 25
SP - 221
EP - 224
JO - Nature Medicine
JF - Nature Medicine
IS - 2
ER -